KENNY HIRSCHI: Open Payments
NPI 1548611494 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 45 payments from 11 companies in 2025. Trend: 2023 $108 · 2024 $160 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $231 |
| E.R. Squibb & Sons, L.L.C. | 6 | $117 |
| Indivior Inc. | 5 | $108 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Supernus Pharmaceuticals, Inc. | 5 | $86 |
| ABBVIE INC. | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Braeburn Inc. | 2 | $30 |
| Tempus AI, Inc | 1 | $14 |
Products named: SPRAVATO, SUBLOCADE, COBENFY, ABILIFY MAINTENA, Qelbree, VRAYLAR, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across UT — which companies pay providers there.
